1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
S2Medical AB (publ)

S2Medical AB (publ)

S2M.ST
S2Medical AB (publ)SE flagStockholm Stock Exchange
0.01
SEK
+0.00
- -
4.67MMarket Cap

Total Valuation

S2Medical AB (publ) carries a market capitalization of 4.67M, placing it among publicly traded companies globally. Its enterprise value stands at 9.35M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap4.67M
Enterprise Value9.35M

Share Statistics

S2Medical AB (publ) currently has 371.53M shares outstanding.

Shares Outstanding371.53M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.01, and the price-to-book ratio stands at 0.64.

PE RatioN/A
PS Ratio1.01
PB Ratio0.64
P/TBV Ratio-5.77
P/FCF Ratio0.69
P/OCF Ratio0.74

Enterprise Valuation

On an enterprise value basis, S2Medical AB (publ) trades at an EV/EBITDA multiple of 4.90 and an EV/FCF ratio of 0.48. The EV/Sales ratio of 0.88 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 4.90 provides insight into valuation relative to core operating earnings.

EV / Sales0.88
EV / EBITDA4.90
EV / EBIT4.90
EV / FCF0.48

Financial Position

S2Medical AB (publ) maintains a current ratio of 0.68, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities.

Current Ratio0.68
Quick Ratio0.18
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage0.47

Financial Efficiency

Return on Equity (ROE)-22.84
Return on Assets (ROA)-6.81
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)176.50
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.41

Stock Price Statistics

S2Medical AB (publ)'s stock has declined approximately -61.48148% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.

Beta (5Y)N/A
52-Week Price Change-61.48148%
50-Day Moving Average0.01
200-Day Moving Average0.01
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, S2Medical AB (publ) generated 10.57M in revenue and converted that into -2.14M in net income, yielding earnings per share of -0.01. EBITDA reached 1.91M, while operating income came in at 1.91M.

Revenue10.57M
Gross Profit9.45M
Operating Income1.91M
Pretax Income-2.14M
Net Income-2.14M
EBITDA1.91M
EBIT1.91M
Earnings Per Share (EPS)-0.01

Balance Sheet

Total book value stands at 16.88M, with working capital of -2.43M providing operational flexibility.

Cash & Cash Equivalents1.37M
Total DebtN/A
Net Debt-1.37M
Equity (Book Value)16.88M
Book Value Per Share0.06
Working Capital-2.43M

Cash Flow

S2Medical AB (publ) produced 14.46M in operating cash flow over the past twelve months. After subtracting -1.14M in capital expenditures, free cash flow totaled 13.31M - equivalent to 0.04 per share.

Operating Cash Flow14.46M
Capital Expenditures-1.14M
Free Cash Flow13.31M
FCF Per Share0.04

Margins

S2Medical AB (publ) operates with a gross margin of 89.46, reflecting its pricing power and cost economics. The operating margin of 18.07 and net profit margin of -20.30 provide insight into operational efficiency.

Gross Margin89.46
Operating Margin18.07
Pretax Margin-20.30
Profit Margin-20.30
EBITDA Margin18.07

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield126.91
FCF Yield145.53

Stock Splits

S2Medical AB (publ)'s most recent stock split took place on June 14, 2023 with a 500:1449 split ratio.

Last Split Date6/14/2023
Split Ratio500:1449

Scores

S2Medical AB (publ) posts an Altman Z-Score of 3.34, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.34